BioHarvest Sciences Inc. (BHSC.CN)

CAD 8.9

(1.71%)

Market Cap (In CAD)

154.21 Million

Revenue (In CAD)

12.67 Million

Net Income (In CAD)

-12.56 Million

Avg. Volume

1776.00

Currency
CAD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.2-9.2
PE
-
EPS
-
Beta Value
1.488
ISIN
CA09076J1084
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Ilan Sobel
Employee Count
-
Website
https://www.bioharvest.com
Ipo Date
2015-10-01
Details
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the need to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.